Tumour necrosis factor haplotypes associated with sensory neuropathy in Asian and Caucasian human immunodeficiency virus patients

Chew, C.S.N. and Cherry, C.L. and Imran, D. and Yunihastuti, E. and Kamarulzaman, A. and Varna, S. and Ismail, R. and Phipps, M. and Aghafar, Z. and Gut, I. and Price, P. (2011) Tumour necrosis factor haplotypes associated with sensory neuropathy in Asian and Caucasian human immunodeficiency virus patients. Tissue Antigens, 77 (2). pp. 126-130. ISSN 0001-2815,

Full text not available from this repository.

Abstract

In human immunodeficiency virus (HIV) patients, neuropathy is a common adverse side effect to some antiretroviral treatments, particularly stavudine. As stavudine is cheap, it is widely used in Asia and Africa. We showed that increasing age and height moderately predict the development of neuropathy. This was improved by the inclusion of tumour necrosis factor (TNF)-1031 (rs1799964). To investigate this association, Malay (n = 64), Chinese (n = 74) and Caucasian patients (n = 37) exposed to stavudine were screened for neuropathy. DNA samples were genotyped for polymorphisms in the central major histocompatibility complex (MHC) near TNF, and haplotypes were derived. The haplotype group FVa6,7,8 (incorporating TNF-1031) was found to be associated with neuropathy in Chinese patients in bivariate analyses (P = 0.03), and in Malays and Chinese in a multivariate analysis correcting for age and height (P = 0.02, P = 0.03, respectively). This trend was also confirmed in Caucasians.

Item Type: Article
Funders: UNSPECIFIED
Additional Information: Chew, C. S. N. Cherry, C. L. Imran, D. Yunihastuti, E. Kamarulzaman, A. Varna, S. Ismail, R. Phipps, M. Aghafar, Z. Gut, I. Price, P.
Uncontrolled Keywords: TNF haplotype;immunogenetics;neuropathy;HIV;NRTI;inflammation
Subjects: R Medicine
Divisions: Faculty of Medicine
Depositing User: Ms azrahani halim
Date Deposited: 04 Feb 2013 01:56
Last Modified: 04 Feb 2013 01:56
URI: http://eprints.um.edu.my/id/eprint/4626

Actions (login required)

View Item View Item